4896-3907 Screening compound: 2-{2-[10-bromo-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepin-6-yl]phenoxy}acetic acid

4896-3907 Screening compound: 2-{2-[10-bromo-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepin-6-yl]phenoxy}acetic acid
4896-3907 Screening compound: 2-{2-[10-bromo-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepin-6-yl]phenoxy}acetic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound 4896-3907
2-{2-[10-bromo-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepin-6-yl]phenoxy}acetic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

4896-3907

Molecular Formula

C22H21BrN4O4S (C22 H21 BrN4 O4 S)

Compound Name

2-{2-[10-bromo-3-(butylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepin-6-yl]phenoxy}acetic acid

IUPAC name

2-{2-[14-bromo-5-(butylsulfanyl)-8-oxa-34610-tetraazatricyclo[9.4.0.0^{27}]pentadeca-1(11)2(7)351214-hexaen-9-yl]phenoxy}acetic acid

SMILES

CCCCSc1nnc(-c(cc(cc2)Br)c2NC(c(cccc2)c2OCC(O)=O)O2)c2n1

InChI

InChI=1S/C22H21BrN4O4S/c1-2-3-10-32-22-25-21-19(26-27-22)15-11-13(23)8-9-16(15)24-20(31-21)14-6-4-5-7-17(14)30-12-18(28)29/h4-9,11,20,24H,2-3,10,12H2,1H3,(H,28,29)/t20-/m1/s1

InChI Key

PPMHYAISEZHYCY-HXUWFJFHSA-N

MDL Number (MFCD)

MFCD04062431

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

517.4

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.564

Distribution Coefficient, logD

1.327

Water Solubility, LogSw

-5.14

Polar Surface Area

88.267

Acid Dissociation Constant (pKa)

3.16

Base Dissociation Constant (pKb)

-1.00

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

27.30

4896-3907 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with 4896-3907 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 4896-3907?
Check Price and Availability of 4896-3907, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 4896-3907 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 4896-3907
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 4896-3907
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 4896-3907 available by request